Cargando…
Prospects of Risk-Sharing Agreements for Innovative Therapies in a Context of Deficit Spending in Bulgaria
Autores principales: | Iskrov, Georgi, Stefanov, Rumen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406092/ https://www.ncbi.nlm.nih.gov/pubmed/25954739 http://dx.doi.org/10.3389/fpubh.2015.00064 |
Ejemplares similares
-
Socio-Economic Burden of Myasthenia Gravis: A Cost-of-Illness Study in Bulgaria
por: Ignatova, Valentina, et al.
Publicado: (2022) -
Multi-Criteria Decision Analysis for Assessment and Appraisal of Orphan Drugs
por: Iskrov, Georgi, et al.
Publicado: (2016) -
Whole-Genome Sequencing in Newborn Screening—Attitudes and Opinions of Bulgarian Pediatricians and Geneticists
por: Iskrov, Georgi, et al.
Publicado: (2017) -
Challenges in mapping European rare disease databases, relevant for ML-based screening technologies in terms of organizational, FAIR and legal principles: scoping review
por: Raycheva, Ralitsa, et al.
Publicado: (2023) -
What is the awareness of rare diseases among medical students? A survey in Bulgaria
por: Hristova-Atanasova, Eleonora, et al.
Publicado: (2023)